U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Medical Products and Tobacco
  5. Center for Drug Evaluation and Research | CDER
  6. Division of Hematology Products (DHP)
  1. Center for Drug Evaluation and Research | CDER

Division of Hematology Products (DHP)

The Office of New Drugs is undergoing a reorganization. This site may be updated in the near future. Please check back often. For more information, please visit Reorganization of the Office of New Drugs with Corresponding Changes to the Office of Translational Sciences and the Office of Pharmaceutical Quality.

Director: Ann Farrell, M.D.
Deputy Director:  Vacant
Associate Deputy Director: Albert Deisseroth, M.D. 
Deputy Director of Safety: Barry Miller (Acting) 

Safety Reviewer: Qin Ryan
Safety Regulatory Project Manager: Diane Leaman
Associate Director of Labeling: Virginia Kwitkowski
CPMS: Theresa Carioti
CPMS: Amy Baird
Project Specialist: Jeimy Flournoy 

The Division of Hematology Products (DHP) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologic Licensing Applications (BLAs) for small molecule agents and biologics used in hematology.

  • The hematology products include those products used predominantly as therapeutic agents in malignant hematological and nonmalignant hematological conditions, such as the treatment of anemias, venous thromboembolism, and platelet disorders.

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Hematology Products
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone: (301) 796-7550
Fax: (301) 796-9845